Affinia Therapeutics, Forge Biologics - Olean Times Herald

Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics’ Pipeline of Next-Generation Gene Therapies to the Clinic

Press Releases

Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership to Advance Affinia Therapeutics’ Pipeline of Next-Generation Gene Therapies to the Clinic

Affinia Therapeutics, Forge Biologics

November 13, 2024

Partnership will include cGMP manufacturing services for AFTX-201, Affinia's investigational gene therapy medicine for BAG3 dilated cardiomyopathy WAL...